Cargando…
Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications
Poly (ADP-ribose) polymerase1 (PARP1) has been reported as a possible target for chemotherapy in many cancer types. However, its action mechanisms and clinical implications for gastric cancer survival are not yet fully understood. Here, we investigated the effect of PARP1 inhibition in the growth of...
Autores principales: | Park, See-Hyoung, Jang, Kyu Yun, Kim, Min Jae, Yoon, Sarah, Jo, Yuna, Kwon, So Mee, Kim, Kyoung Min, Kwon, Keun Sang, Kim, Chan Young, Woo, Hyun Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792594/ https://www.ncbi.nlm.nih.gov/pubmed/26540566 |
Ejemplares similares
-
Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients()
por: Park, See-Hyoung, et al.
Publicado: (2015) -
Mitoribosome Defect in Hepatocellular Carcinoma Promotes an Aggressive Phenotype with Suppressed Immune Reaction
por: Kwon, So Mee, et al.
Publicado: (2020) -
Individual and Combined Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predict Shorter Survival of Soft Tissue Sarcoma Patients
por: Kim, Kyoung Min, et al.
Publicado: (2016) -
The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma
por: Park, Hye Jeong, et al.
Publicado: (2018) -
Mitoxantrone induces apoptosis in osteosarcoma cells through regulation of the Akt/FOXO3 pathway
por: Park, See-Hyoung, et al.
Publicado: (2018)